Gene · 57167
Papers3,058
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,058
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm of the Esophagogastric Junction with Enteroblastic Differentiation and Morphologic-Immunophenotypic Discordance: A Case Report with Five-Year Disease-Free Survival. | Surg Case Rep | 2026 | 41969299 | PubTator, text mining | PubMed |
| SALL4 Transcriptional Regulates CRIPTO to Boost the Stemness and Doxorubicin Hydrochloride Resistance of Colon Cancer Cells. | Tohoku J Exp Med | 2026 | 41951377 | PubTator, text mining | PubMed |
| The Multifaceted Legacy of Thalidomide: Chemistry and Biology Driving Modern Drug Design. | ChemMedChem | 2026 | 41931005 | PubTator, text mining | PubMed |
| From PD-L1 downregulation to biomarker-driven immunotherapy design: advancing translational application of SALL4-targeted PEN-FFW in breast cancer. | Immunol Res | 2026 | 41925953 | PubTator, text mining | PubMed |
| Apigenin Inhibits the Growth of Esophageal Squamous Cell Carcinoma (ESCC) Cells by Harnessing the Expression of MicroRNAs. | Biomolecules | 2026 | 41897301 | PubTator, text mining | PubMed |
| Differential roles of SALL transcription factors in breast cancer: Potential biomarkers. | Comput Biol Med | 2026 | 41886924 | PubTator, text mining | PubMed |
| PepLM-GNN: A graph neural network framework leveraging pre-trained language models for peptide-protein binding prediction. | PLoS Comput Biol | 2026 | 41875143 | PubTator, text mining | PubMed |
| Update on Congenital Cranial Dysinnervation Disorders (CCDDs). | Int Ophthalmol Clin | 2026 | 41870107 | PubTator, text mining | PubMed |
| TRIM21-Mediated ubiquitination of FBL suppresses PI3K/AKT signaling and tumor progression in clear cell renal cell carcinoma. | Cell Mol Life Sci | 2026 | 41863623 | PubTator, text mining | PubMed |
| Investigating the role of FKBP4 in testis germ cell tumor via integrated in silico approach. | In Silico Pharmacol | 2026 | 41858337 | PubTator, text mining | PubMed |
| Computational identification of lineage-committed precursors in mammalian organogenesis reveals a novel hematopoietic enhancer regulating Bhlhe41 expression. | Brief Bioinform | 2026 | 41838874 | PubTator, text mining | PubMed |
| Choriocarcinoma in the Cervix: Case Report of a Challenging Differential Diagnosis. | Case Rep Obstet Gynecol | 2026 | 41810059 | PubTator, text mining | PubMed |
| First-Line Treatment of Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Case Report and Review of the Literature. | Case Rep Oncol Med | 2026 | 41809723 | PubTator, text mining | PubMed |
| Diagnostic dilemmas in hepatoid adenocarcinoma of the stomach: Navigating clinical and pathological loopholes. | World J Methodol | 2026 | 41809177 | PubTator, text mining | PubMed |
| Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan. | Int J Urol | 2026 | 41808310 | PubTator, text mining | PubMed |
| Dysgerminoma of the ovary presenting as acute abdomen with intratumoural gas image: a diagnostic challenge suspected as a gastrointestinal stromal tumour. | BMJ Case Rep | 2026 | 41806988 | PubTator, text mining | PubMed |
| DICER1 -Related Primitive Polyphenotypic Neoplasm : A Report of 15 Cases of an Underrecognized Tumor of the Gynecologic Tract and Peritoneum. | Am J Surg Pathol | 2026 | 41801179 | PubTator, text mining | PubMed |
| Anaplastic Lymphoma Kinase (ALK)-Positive Large B-cell Lymphoma in Children: A Case Report and Review of Literature. | Cureus | 2026 | 41798535 | PubTator, text mining | PubMed |
| Primary Pericardial Angiosarcoma Demonstrating Initial Response Followed by Progression on First-Line Chemotherapy: A Case Report. | Clin Case Rep | 2026 | 41797739 | PubTator, text mining | PubMed |
| TCL1A mediates DNA methylation defects in recurrent hydatidiform mole with NLRP7 pathogenic variants. | Nat Commun | 2026 | 41786744 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57167/papers?page=3